Latest Legal And Compliance News

humm Group Limited has posted a statutory profit after tax of $13.9 million for the half-year ended 31 December 2025, marking a 49% decline from the previous year, driven by increased credit losses and legal costs. Despite challenges, the company declared a fully franked interim dividend of 1.5 cents per share.

AuMake Limited reports positive operating cashflow and a strategic pivot into China’s high-growth OTC medicine market, supported by a $1.5 million capital raise and significant governance reforms.

Fluence Corporation reported robust revenue and EBITDA growth in FY 2025, driven by strong contributions from its Ivory Coast project and expanding Smart Product Solutions. Leadership changes aim to accelerate growth as the company eyes continued momentum in 2026.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Light & Wonder, Inc. has amended its credit agreement to introduce a new $2.13 billion tranche of term loans due in 2029, replacing prior debt and reducing borrowing costs. The move reflects a strategic refinancing amid its Nasdaq delisting process.

Collins Foods Limited reported solid half-year growth with revenue up 6.6% and net profit rising 12.7%, driven by strong performance in its KFC operations across Australia and Europe. The company declared a fully franked interim dividend of 13 cents per share, while navigating increased provisions linked to wage compliance and ongoing class action litigation.

Fiducian Group Limited has reported a robust 23% increase in net profit after tax for the year ended June 2025, driven by strong inflows and resilient performance across its financial planning, platform administration, and investment management segments despite challenging market conditions.

DigitalX Limited has responded to ASX queries, affirming the legality of its cryptocurrency treasury strategy and outlining plans to expand Bitcoin holdings significantly by 2027 to support its digital asset business.

Platinum Capital faces a significant hurdle as L1 Capital, holding nearly 17% of shares, declares opposition to its proposed restructuring scheme. The Board remains supportive but is exploring alternatives.

Spenda Limited reported a robust Q3 FY25 with cash receipts soaring 160% year-on-year despite a strategic sale of its invoice finance loan book. The company secured a $3 million loan facility and forecasts a record-breaking quarter ahead.

Inca Minerals has formally agreed with Stunalara Metals to extend the timetable for their off-market takeover offer, setting new key dates through early April 2025.

Medlab Clinical reports a near-empty cash balance and zero receipts in Q2 2025, while actively pursuing a business acquisition ahead of its ASX removal date.